These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8741307)

  • 1. Adverse events associated with MMR vaccines in Japan.
    Kimura M; Kuno-Sakai H; Yamazaki S; Yamada A; Hishiyama M; Kamiya H; Ueda K; Murase T; Hirayama M; Oya A; Nozaki S; Murata R
    Acta Paediatr Jpn; 1996 Jun; 38(3):205-11. PubMed ID: 8741307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aseptic meningitis as a complication of mumps vaccination.
    Sugiura A; Yamada A
    Pediatr Infect Dis J; 1991 Mar; 10(3):209-13. PubMed ID: 2041668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project.
    Black S; Shinefield H; Ray P; Lewis E; Chen R; Glasser J; Hadler S; Hardy J; Rhodes P; Swint E; Davis R; Thompson R; Mullooly J; Marcy M; Vadheim C; Ward J; Rastogi S; Wise R
    Pediatr Infect Dis J; 1997 May; 16(5):500-3. PubMed ID: 9154545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.
    Dourado I; Cunha S; Teixeira MG; Farrington CP; Melo A; Lucena R; Barreto ML
    Am J Epidemiol; 2000 Mar; 151(5):524-30. PubMed ID: 10707922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine.
    Fujinaga T; Motegi Y; Tamura H; Kuroume T
    Pediatr Infect Dis J; 1991 Mar; 10(3):204-9. PubMed ID: 2041667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan.
    Ueda K; Miyazaki C; Hidaka Y; Okada K; Kusuhara K; Kadoya R
    Lancet; 1995 Sep; 346(8976):701-2. PubMed ID: 7658837
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children.
    Miller E; Goldacre M; Pugh S; Colville A; Farrington P; Flower A; Nash J; MacFarlane L; Tettmar R
    Lancet; 1993 Apr; 341(8851):979-82. PubMed ID: 8096942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit].
    Wiersbitzky S; Bruns R; Peters A; Mentel R
    Kinderarztl Prax; 1992 Oct; 60(7):203-5. PubMed ID: 1359186
    [No Abstract]   [Full Text] [Related]  

  • 11. MMR vaccine coverage at 24 months stabilises in the UK.
    Commun Dis Rep CDR Wkly; 1999 Mar; 9(13):113, 116. PubMed ID: 10230112
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aseptic meningitis after mumps vaccination].
    Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
    Therapie; 1996; 51(6):681-3. PubMed ID: 9164005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
    Farrington P; Pugh S; Colville A; Flower A; Nash J; Morgan-Capner P; Rush M; Miller E
    Lancet; 1995 Mar; 345(8949):567-9. PubMed ID: 7619183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
    Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B
    Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMR vaccination and autism.
    Wakefield AJ
    Lancet; 1999 Sep; 354(9182):949-50. PubMed ID: 10489978
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningoencephalitis associated with MMR vaccine.
    Maguire HC; Begg NT; Handford SG
    CDR (Lond Engl Rev); 1991 May; 1(6):R60-1. PubMed ID: 1688304
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles, mumps, and rubella: recommendations for children/adolescents.
    Nurse Pract; 1996 Oct; 21(10):88, 91-2, 94. PubMed ID: 8895194
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
    Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG
    Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
    Usonis V; Bakasenas V; Kaufhold A; Chitour K; Clemens R
    Pediatr Infect Dis J; 1999 Jan; 18(1):42-8. PubMed ID: 9951979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.